FatiAbGen is a leading antibody engineering company developing best in class multi-modality antibodies for difficult targets in high unmet need disease in oncology and immunology. The leading asset is a superior anti-mesothelin ADC with unique characteristics and strong pre-clinical data.
FatiAbGen Co., Ltd.
Category:
Venture
Main Business Area
FatiAbGen is a company that focuses on innovating novel immunotoxin antibody assets and regulating stem cell fate with cutting-edge technologies.
Contact Details | A-512~515, 6, Jiphyeonjungang 7-ro, Sejong-si +82-44-715-7707 |
---|
Find out more companies
Related products
-
Venture
Medigen Human Care
T cell immunotherapies for solid tumors, vaccine safety and natural immunity
-
Venture
K-Cell Co., Ltd.